conditions, within the addictive process, can be evaluated in the home-cage environment. These are (a) the acquisition of ethanol intake, (b) the maintenance of ethanol intake, and (c) relapse-like drinking of ethanol. In turn, each of these three primary conditions can be tested with continuous access (i.e., 24 h/day) or limited access (i.e., a set period of access each test day such as the first hour of the dark cycle) ethanol availability. Note that brief examples are given in the text of Section 5, whereas explicit details of published studies examining the effects of neuropharmacological treatments on ethanol intake in AA, HAD, P and sP rats are described in Table 4. Also, the doses noted in Table 4 are the doses that exerted the significant effects reported in the table (i.e., the doses inducing the drug’s noted effect on ethanol intake are the only doses listed).
